Financial Ratios Intuitive Surgical, Inc.
Equities
ISRG
US46120E6023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
After hours 03:40:45 am | |||
| 422.06 USD | +0.77% |
|
420.00 | -0.49% |
| 02/06 | Intuitive Surgical Insider Sold Shares Worth $2,365,594, According to a Recent SEC Filing | MT |
| 02/06 | Deutsche Bank Adjusts Intuitive Surgical PT to $366 From $440, Maintains Sell Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.21 | 7.56 | 7.77 | 8.67 | 9.39 | |||||
Return on Total Capital | 10.4 | 8.63 | 8.94 | 9.82 | 10.58 | |||||
Return On Equity % | 15.92 | 11.66 | 14.83 | 15.62 | 16.69 | |||||
Return on Common Equity | 15.76 | 11.53 | 14.77 | 15.62 | 16.67 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 69.32 | 67.44 | 66.39 | 67.46 | 66 | |||||
SG&A Margin | 25.68 | 27.51 | 27.57 | 25.37 | 23.7 | |||||
EBITDA Margin % | 37.27 | 31.48 | 30.45 | 33.83 | 35.35 | |||||
EBITA Margin % | 32.37 | 26.24 | 25.08 | 28.58 | 29.4 | |||||
EBIT Margin % | 31.89 | 25.8 | 24.8 | 28.38 | 29.27 | |||||
Income From Continuing Operations Margin % | 30.26 | 21.61 | 25.51 | 27.99 | 28.58 | |||||
Net Income Margin % | 29.85 | 21.25 | 25.24 | 27.81 | 28.38 | |||||
Net Avail. For Common Margin % | 29.85 | 21.25 | 25.24 | 27.81 | 28.38 | |||||
Normalized Net Income Margin | 20.39 | 16.56 | 16.98 | 20.06 | 20.37 | |||||
Levered Free Cash Flow Margin | 27.97 | 17.97 | 10.94 | 14.33 | 22.6 | |||||
Unlevered Free Cash Flow Margin | 27.97 | 17.97 | 10.94 | 14.33 | 22.6 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.46 | 0.47 | 0.5 | 0.49 | 0.51 | |||||
Fixed Assets Turnover | 3.18 | 2.82 | 2.35 | 1.99 | 1.96 | |||||
Receivables Turnover (Average Receivables) | 7.05 | 6.33 | 6.09 | 6.37 | 6.74 | |||||
Inventory Turnover (Average Inventory) | 2.95 | 2.74 | 2.27 | 2.01 | 2.06 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.08 | 4.4 | 4.76 | 4.07 | 4.87 | |||||
Quick Ratio | 4.46 | 3.65 | 3.91 | 3.08 | 3.77 | |||||
Operating Cash Flow to Current Liabilities | 1.82 | 1.05 | 1.09 | 1.38 | 1.51 | |||||
Days Sales Outstanding (Average Receivables) | 51.76 | 57.67 | 59.96 | 57.5 | 54.13 | |||||
Days Outstanding Inventory (Average Inventory) | 123.84 | 133.33 | 161.1 | 182.32 | 177.42 | |||||
Average Days Payable Outstanding | 21.3 | 20.99 | 22.51 | 23.43 | 21.68 | |||||
Cash Conversion Cycle (Average Days) | 154.3 | 170.02 | 198.56 | 216.39 | 209.87 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.73 | 0.86 | 0.67 | 0.88 | 0.95 | |||||
Total Debt / Total Capital | 0.72 | 0.85 | 0.67 | 0.88 | 0.94 | |||||
LT Debt/Equity | 0.56 | 0.63 | 0.48 | 0.68 | 0.74 | |||||
Long-Term Debt / Total Capital | 0.55 | 0.62 | 0.48 | 0.67 | 0.73 | |||||
Total Liabilities / Total Assets | 11.83 | 14.35 | 13.24 | 11.81 | 12.3 | |||||
Total Debt / EBITDA | 0.04 | 0.05 | 0.04 | 0.05 | 0.05 | |||||
Net Debt / EBITDA | -1.93 | -2.03 | -2.34 | -1.35 | -1.6 | |||||
Total Debt / (EBITDA - Capex) | 0.05 | 0.07 | 0.08 | 0.08 | 0.06 | |||||
Net Debt / (EBITDA - Capex) | -2.31 | -2.77 | -4.54 | -2.21 | -1.88 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 31.01 | 8.97 | 14.49 | 17.24 | 20.5 | |||||
Gross Profit, 1 Yr. Growth % | 38.35 | 6 | 12.71 | 19.13 | 17.89 | |||||
EBITDA, 1 Yr. Growth % | 61.17 | -7.96 | 10.72 | 30.28 | 26.86 | |||||
EBITA, 1 Yr. Growth % | 68.1 | -11.65 | 9.43 | 33.56 | 25.07 | |||||
EBIT, 1 Yr. Growth % | 73.46 | -11.85 | 10.07 | 34.15 | 25.4 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 61.99 | -22.2 | 35.18 | 28.62 | 23.06 | |||||
Net Income, 1 Yr. Growth % | 60.72 | -22.43 | 35.98 | 29.18 | 22.97 | |||||
Normalized Net Income, 1 Yr. Growth % | 63.16 | -11.53 | 17.4 | 39.03 | 23.79 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 58.5 | -21.67 | 37.81 | 27.63 | 22.59 | |||||
Accounts Receivable, 1 Yr. Growth % | 22.9 | 20.19 | 18.09 | 7.05 | 20 | |||||
Inventory, 1 Yr. Growth % | -2.39 | 52.14 | 36.65 | 21.84 | 23.72 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 18.86 | 25.92 | 47.24 | 32.24 | 14.85 | |||||
Total Assets, 1 Yr. Growth % | 21.36 | -4.29 | 19.02 | 21.38 | 9.15 | |||||
Tangible Book Value, 1 Yr. Growth % | 23.29 | -7.34 | 21.39 | 24.33 | 8.55 | |||||
Common Equity, 1 Yr. Growth % | 22.29 | -7.22 | 20.52 | 23.49 | 8.46 | |||||
Cash From Operations, 1 Yr. Growth % | 40.72 | -28.65 | 21.67 | 33.15 | 25.49 | |||||
Capital Expenditures, 1 Yr. Growth % | 3.51 | 56.82 | 99.89 | 4.42 | -51.42 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 77.32 | -30.62 | -30.12 | 53.62 | 92.15 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 77.32 | -30.62 | -30.12 | 53.62 | 92.15 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 12.92 | 19.48 | 11.7 | 15.86 | 18.86 | |||||
Gross Profit, 2 Yr. CAGR % | 12.82 | 21.1 | 9.31 | 15.88 | 18.51 | |||||
EBITDA, 2 Yr. CAGR % | 16.27 | 21.8 | 0.95 | 20.1 | 28.08 | |||||
EBITA, 2 Yr. CAGR % | 14.19 | 21.86 | -1.67 | 20.9 | 28.67 | |||||
EBIT, 2 Yr. CAGR % | 15.1 | 23.65 | -1.5 | 21.51 | 29.12 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 11.83 | 12.26 | 2.55 | 31.86 | 25.81 | |||||
Net Income, 2 Yr. CAGR % | 11.17 | 11.66 | 2.7 | 32.53 | 26.03 | |||||
Normalized Net Income, 2 Yr. CAGR % | 11.74 | 20.15 | 1.91 | 28.61 | 30.44 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 10.02 | 11.42 | 3.89 | 32.62 | 25.08 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.28 | 21.54 | 19.14 | 12.43 | 13.34 | |||||
Inventory, 2 Yr. CAGR % | -0.71 | 21.86 | 44.19 | 29.04 | 22.78 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 23.8 | 22.34 | 36.16 | 39.54 | 23.24 | |||||
Total Assets, 2 Yr. CAGR % | 18.01 | 7.78 | 6.73 | 20.19 | 15.1 | |||||
Tangible Book Value, 2 Yr. CAGR % | 21.01 | 6.88 | 6.05 | 22.85 | 16.17 | |||||
Common Equity, 2 Yr. CAGR % | 20.01 | 6.52 | 5.74 | 22 | 15.73 | |||||
Cash From Operations, 2 Yr. CAGR % | 14.34 | 0.2 | -6.83 | 27.28 | 29.26 | |||||
Capital Expenditures, 2 Yr. CAGR % | -8.86 | 24.86 | 77.05 | 44.47 | -28.78 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 24.94 | 11.4 | -30.46 | 3.61 | 70.86 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 24.94 | 11.4 | -30.46 | 3.61 | 70.86 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15.31 | 11.58 | 17.8 | 13.51 | 17.39 | |||||
Gross Profit, 3 Yr. CAGR % | 14.98 | 10.5 | 18.24 | 12.49 | 16.55 | |||||
EBITDA, 3 Yr. CAGR % | 15.97 | 7.56 | 17.99 | 9.91 | 22.01 | |||||
EBITA, 3 Yr. CAGR % | 13.66 | 4.83 | 17.57 | 8.89 | 21.91 | |||||
EBIT, 3 Yr. CAGR % | 13.53 | 5.31 | 18.95 | 9.18 | 22.43 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 15.38 | -0.91 | 19.43 | 10.59 | 28.86 | |||||
Net Income, 3 Yr. CAGR % | 14.76 | -1.4 | 19.24 | 10.86 | 29.26 | |||||
Normalized Net Income, 3 Yr. CAGR % | 11.86 | 3.38 | 19.22 | 12.89 | 26.5 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 13.78 | -1.76 | 19.6 | 11.27 | 29.19 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.78 | 14.86 | 20.38 | 14.96 | 14.9 | |||||
Inventory, 3 Yr. CAGR % | 12.81 | 14.47 | 26.6 | 36.32 | 27.24 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 33.93 | 24.5 | 30.13 | 34.84 | 30.77 | |||||
Total Assets, 3 Yr. CAGR % | 19.99 | 10.05 | 11.4 | 11.41 | 16.4 | |||||
Tangible Book Value, 3 Yr. CAGR % | 21.71 | 10.71 | 11.51 | 11.83 | 17.88 | |||||
Common Equity, 3 Yr. CAGR % | 21.24 | 10.14 | 11 | 11.36 | 17.31 | |||||
Cash From Operations, 3 Yr. CAGR % | 21.34 | -2.29 | 6.9 | 4.95 | 26.68 | |||||
Capital Expenditures, 3 Yr. CAGR % | 23.56 | 7.75 | 46.06 | 48.47 | 0.46 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 30.44 | 2.99 | -4.72 | -9.43 | 26.83 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 30.44 | 2.99 | -4.72 | -9.43 | 26.83 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.1 | 14.67 | 13.85 | 13.27 | 18.22 | |||||
Gross Profit, 5 Yr. CAGR % | 15.9 | 13.76 | 12.68 | 12.62 | 18.35 | |||||
EBITDA, 5 Yr. CAGR % | 15.16 | 11.09 | 9.71 | 12.41 | 21.92 | |||||
EBITA, 5 Yr. CAGR % | 13.53 | 8.71 | 7.26 | 10.98 | 21.89 | |||||
EBIT, 5 Yr. CAGR % | 13.62 | 8.59 | 7.26 | 11.51 | 22.92 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 18.54 | 14.91 | 10.07 | 11.09 | 21.94 | |||||
Net Income, 5 Yr. CAGR % | 18.22 | 14.53 | 9.78 | 10.98 | 21.91 | |||||
Normalized Net Income, 5 Yr. CAGR % | 13.31 | 7.92 | 7.77 | 12.43 | 23.5 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 17.43 | 13.67 | 9.72 | 10.77 | 21.77 | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.19 | 14.32 | 11.56 | 13.88 | 17.51 | |||||
Inventory, 5 Yr. CAGR % | 26.35 | 29.93 | 24.44 | 20.09 | 25.06 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 33.6 | 31.99 | 34.82 | 30.31 | 27.33 | |||||
Total Assets, 5 Yr. CAGR % | 15.88 | 17.56 | 14.5 | 14 | 12.87 | |||||
Tangible Book Value, 5 Yr. CAGR % | 15.68 | 18.52 | 15.19 | 15.41 | 13.35 | |||||
Common Equity, 5 Yr. CAGR % | 15.55 | 18.23 | 14.78 | 14.74 | 12.87 | |||||
Cash From Operations, 5 Yr. CAGR % | 13.96 | 5.44 | 9.17 | 8.61 | 15.34 | |||||
Capital Expenditures, 5 Yr. CAGR % | 45.67 | 22.79 | 41.53 | 21.16 | 9.59 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 12.95 | 9.72 | 1.6 | 3.19 | 20.35 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 12.95 | 9.72 | 1.6 | 3.19 | 20.35 |
- Stock Market
- Equities
- ISRG Stock
- Financials Intuitive Surgical, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















